Overview

Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This research is being done to find out if daily use of the drug levetiracetam can improve memory function in individuals with memory problems like those associated with Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD).
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
National Institute on Aging (NIA)
Treatments:
Etiracetam
Levetiracetam
Piracetam